空间贝叶斯半参数考克斯-莱鲁斯模型中风患者住院治疗:生存方面的方面
Aswi Aswi1, Bobby Poerwanto1, Nurussyariah Hammado2
1Statistics Department, Universitas Negeri Makassar.
Geospatial health
|July 21, 2025
概括
这项研究使用空间脆弱模型增强了中风住院患者的生存分析. 研究结果显示,糖尿病会对康复产生负面影响,而高胆固醇血和缺血性中风会改善康复.
科学领域:
- 生物统计学 生物统计学
- 流行病学 流行病学
- 空间分析 空间分析
背景情况:
- 生存分析对于时间到事件数据至关重要.
- 区域数据中的空间相关性可以使用条件自回归 (CAR) 先验来建模.
- 区域级脆弱性术语可以将空间效应纳入生存模型中.
研究的目的:
- 通过使用Leroux CAR先前的空间脆弱性术语来扩展贝叶斯-考克斯半参数模型.
- 分析印尼马卡萨尔的中风住院情况,重点关注地理分布,住院时间 (LOS) 和患者的治疗结果.
- 确定影响中风患者康复的因素.
主要方法:
- 贝叶斯的考克斯半参数模型扩展.
- 将一个空间脆弱性术语与Leroux CAR先例相结合.
- 从2021年4月到2024年6月的医疗记录分析,包括LOS,出院结果和临床变量.
主要成果:
- 糖尿病与较低的康复率有关.
- 高胆固醇和缺血性中风类型与血液性中风相比,与更快的恢复有关.
- 空间脆弱模型改善了对中风住院模式的描述.
结论:
- 空间脆弱模型有效地捕捉了中风住院数据中的空间依赖.
- 糖尿病,中风类型和高胆固醇血症是中风患者康复的重要预测因素.
- 了解这些因素可以为有针对性的干预提供信息,并改善患者的治疗结果.
相关概念视频
Assumptions of Survival Analysis
199
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
199
Parametric Survival Analysis: Weibull and Exponential Methods
619
Parametric survival analysis models survival data by assuming a specific probability distribution for the time until an event occurs. The Weibull and exponential distributions are two of the most commonly used methods in this context, due to their versatility and relatively straightforward application.
Weibull Distribution
The Weibull distribution is a flexible model used in parametric survival analysis. It can handle both increasing and decreasing hazard rates, depending on its shape parameter...
Weibull Distribution
The Weibull distribution is a flexible model used in parametric survival analysis. It can handle both increasing and decreasing hazard rates, depending on its shape parameter...
619
Introduction To Survival Analysis
402
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
The primary goal of survival analysis is to estimate survival time—the time...
402
Comparing the Survival Analysis of Two or More Groups
291
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
291
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
128
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
128
Cancer Survival Analysis
456
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
456


